University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
NCT Number: NCT00014898
We are examining the past exposure to lead in 250 well characterized children with ADHD, and a suitable group of controls. Our measure of past exposure is bone lead levels obtained by XRay fluorescence spectroscopy, a relatively new way of estimating bone lead concentrations, and by inference, body lead burdens. By comparing the lead concentrations in these two groups, controlling for other factors which could confound, we will estimate odds ratios for ADHD given elevated bone lead, and estimate the contribution of lead to this disease of childhood.
Looking for future studies?
Notify Me10 year–18 year
All sexes
Observational
Pittsburgh, Pennsylvania, 15213, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Case subjects are drawn from adolescents aged 10 to 18 previously seen at Western Psychiatric Institute and Clinic for evaluation, and meet the DSM-IIIR criteria for diagnosis of ADHD based on a structured parent interview and standardized parent and teacher rating scales. Cases were also systematically observed and evaluated in the summer treatment program between 1987 and 1996 at WPIC. Controls are demographically matched non-ADHD adolescents, recruited from surrounding communities and pediatric practices.
National Institute of Environmental Health Sciences (NIEHS)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05200936
ADHD, Attention Deficit Disorder
Maastricht, Netherlands
View Trial DetailsNCT06491836
Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity
Cairo, Abbassia, Egypt
View Trial DetailsNCT05406414
Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity
Aarhus C, Denmark
View Trial DetailsNCT01841151
Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity
Stockholm, Sweden
View Trial Details